Publications by authors named "Pier L Temporelli"

Claim this Profile
A
Arterial hypertension-attributable mortality in Europe, 2012-2021.
Marco Zuin, Alberto Mazza, Alessandro Maloberti, Chiara Tognola, Giovambattista Desideri, Pier Luigi Temporelli

J Hypertens· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Telenursing in cardiology: literature review and current scientific evidence].
Elisabetta Loverre, Sara Doimo, Marco Mojoli, Simone Cappannelli, Marco Zuin, Pier Luigi Temporelli

G Ital Cardiol (Rome)· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus document on the role of plasma triglycerides in cardiovascular disease from the Italian Society for the Study of Atherosclerosis (SISA).
Alberto Zambon, Luigi Gentile, Federica Galimberti, Enzo Manzato, Andrea Giaccari, Pier Luigi Temporelli

Nutr Metab Cardiovasc Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alcoholic cardiomyopathy-attributed mortality in Europe, 2012-20.
Marco Zuin, Fernando Domínguez, Chiara Dalla Valle, Alessandro Maloberti, Catia De Rosa, Pier Luigi Temporelli

Eur Heart J Qual Care Clin Outcomes· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[ANMCO Position paper: Multidimensional assessment tools for the elderly with chronic heart diseases].
Maurizio Giuseppe Abrignani, Michela Barisone, Tullio Usmiani, Giuseppe Zuccalà, Simone Cappannelli, Pier Luigi Temporelli

G Ital Cardiol (Rome)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute pharmacologic management of myocardial infarction in patients undergoing percutaneous coronary intervention: insights from the Italian nationwide EYESHOT-2 prospective registry.
Marco Zuin, Donata Lucci, Paolo Calabrò, Antonino Nicosia, Emanuele Tizzani, Pier Luigi Temporelli

Eur Heart J Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ambulatory blood pressure monitoring in arterial hypertension.
Marco Zuin, Alberto Mazza, Alessandro Maloberti, Chiara Tognola, Giovambattista Desideri, Pier Luigi Temporelli

Intern Emerg Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LDL-cholesterol levels and lipid lowering therapy in secondary prevention. Baseline data from the BRING-UP prospective registry.
Furio Colivicchi, Gianna Fabbri, Fabrizio Oliva, Maurizio Giuseppe Abrignani, Marcello Arca, Pier Luigi Temporelli

Int J Cardiol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart failure-attributed mortality in Europe, 2012-2021.
Marco Zuin, Pier Luigi Temporelli, Marco Metra, Gianluigi Savarese, Gianluca Rigatelli

Eur J Heart Fail· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Concepts for the Estimation of Lifetime Cardiovascular Risk.
Marco Zuin, Claudio Bilato, Pier Luigi Temporelli

High Blood Press Cardiovasc Prev· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The BRING-UP Prevention study: a national participation model for the improvement of secondary prevention strategies].
Furio Colivicchi, Francesco Orso, Fabrizio Oliva, Maurizio Giuseppe Abrignani, Marcello Arca, Pier Luigi Temporelli

G Ital Cardiol (Rome)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pivotal Role of an Early Post-Acute Cardiac Rehabilitation as an Evidence-Based Management of Left Ventricular Assist Device Patients.
Massimo Pistono, Andrea Giordano, Marco Gnemmi, Fabiana Isabella Gambarin, Mario Granata, Pier Luigi Temporelli

Artif Organs· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Oral semaglutide: why we can no longer do without it?].
Pier Luigi Temporelli, Andrea Di Lenarda, Riccardo Candido

G Ital Cardiol (Rome)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Hypertension Management: Insights from the Latest European Guidelines.
Marco Zuin, Chiara Tognola, Alessandro Maloberti, Gianfranco Parati, Stefania Angela Di Fusco, Pier Luigi Temporelli

J Cardiovasc Dev Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two still unanswered questions about uric acid and cardiovascular prevention: Is a specific uric acid cut-off needed? Is hypouricemic treatment able to reduce cardiovascular risk?
Alessandro Maloberti, Valentina Colombo, Francesca Daus, Lorenzo De Censi, Maurizio Giuseppe Abrignani, Pier Luigi Temporelli

Nutr Metab Cardiovasc Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Ten questions about hormone replacement therapy and cardiovascular risk].
Vered Gil Ad, Stefania Angela Di Fusco, Maria Teresa Manes, Beatrice Scardovi, Daniela Pavan, Pier Luigi Temporelli

G Ital Cardiol (Rome)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Is there still a role today for ECG stress testing in ischemic heart disease? Beyond ST-segment depression].
Pier Luigi Temporelli, Giuseppe Di Pasquale, Raffaele De Caterina

G Ital Cardiol (Rome)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral semaglutide: an innovative paradigm in the management of cardiovascular risk in patients with Type 2 diabetes.
Pier Luigi Temporelli

Eur Heart J Suppl· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of PCSK9 inhibitors in venous thromboembolism: current evidence and unmet clinical needs.
Marco Zuin, Alberto Corsini, Chiara Dalla Valle, Catia De Rosa, Alessandro Maloberti, Pier Luigi Temporelli

Eur Heart J Cardiovasc Pharmacother· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[An anniversary celebration: for a tobacco-free next generation].
Giuseppe Di Pasquale, Pier Luigi Temporelli

G Ital Cardiol (Rome)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Potassium role in the human body and clinical implications of hyperkalemia].
Giulio Binaghi, Maurizio Giuseppe Abrignani, Pier Luigi Temporelli, Matteo Casula, Alessandro Maloberti

G Ital Cardiol (Rome)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-related differences in demographics, diagnosis and management of patients with chronic coronary syndromes.
Marco Mojoli, Pier Luigi Temporelli, Daniela Pavan, Maurizio Giuseppe Abrignani, Lucio Gonzini

J Cardiovasc Med (Hagerstown)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Substance abuse and cardiovascular risk: energy drinks].
Giuseppe Ciliberti, Maurizio Giuseppe Abrignani, Filippo Zilio, Pier Luigi Temporelli, Francesco Ciccirillo

G Ital Cardiol (Rome)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of glucagon-like peptide-1 agonists in obesity and heart failure with preserved ejection fraction.
Pier Luigi Temporelli

Eur Heart J Suppl· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart Failure with Preserved Ejection Fraction: How to Deal with This Chameleon.
Fabiana Lucà, Fabrizio Oliva, Maurizio Giuseppe Abrignani, Stefania Angela Di Fusco, Mauro Gori, Pier Luigi Temporelli

J Clin Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis